Mingbo Su

1.6k total citations
43 papers, 1.2k citations indexed

About

Mingbo Su is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mingbo Su has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mingbo Su's work include Histone Deacetylase Inhibitors Research (19 papers), Peptidase Inhibition and Analysis (15 papers) and Protein Degradation and Inhibitors (12 papers). Mingbo Su is often cited by papers focused on Histone Deacetylase Inhibitors Research (19 papers), Peptidase Inhibition and Analysis (15 papers) and Protein Degradation and Inhibitors (12 papers). Mingbo Su collaborates with scholars based in China, Australia and Norway. Mingbo Su's co-authors include Jia Li, Fajun Nan, Yubo Zhou, Wei Lü, Jing-Ya Li, Yi Chen, Li-Fang Yu, Xuan Zhang, Tao Pang and Yi Zang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Mingbo Su

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingbo Su China	22	810	393	208	164	108	43	1.2k
Bruce Wisely United States	10	532 0.7×	119 0.3×	339 1.6×	245 1.5×	39 0.4×	11	1.2k
Navnath S. Gavande United States	20	791 1.0×	215 0.5×	242 1.2×	32 0.2×	84 0.8×	52	1.2k
Li-Fang Yu China	24	853 1.1×	430 1.1×	73 0.4×	120 0.7×	243 2.3×	63	1.4k
Tetsuo Ohnuki Japan	16	639 0.8×	395 1.0×	217 1.0×	45 0.3×	208 1.9×	32	1.1k
T.R. Santhoshkumar India	20	702 0.9×	102 0.3×	169 0.8×	18 0.1×	128 1.2×	53	1.2k
Robert W. Curley United States	23	1.2k 1.4×	237 0.6×	84 0.4×	30 0.2×	61 0.6×	92	1.7k
Henrik Sune Andersen Denmark	16	1.4k 1.7×	170 0.4×	194 0.9×	97 0.6×	38 0.4×	22	1.6k
T Yoshimoto Japan	16	573 0.7×	207 0.5×	57 0.3×	29 0.2×	363 3.4×	26	1.2k
Fukiko Kojima Japan	16	680 0.8×	364 0.9×	293 1.4×	66 0.4×	209 1.9×	46	1.1k
Nicholas J. Bach United States	13	576 0.7×	285 0.7×	253 1.2×	64 0.4×	129 1.2×	31	1.1k

Countries citing papers authored by Mingbo Su

Since Specialization

Citations

This map shows the geographic impact of Mingbo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingbo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingbo Su more than expected).

Fields of papers citing papers by Mingbo Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingbo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingbo Su. The network helps show where Mingbo Su may publish in the future.

Co-authorship network of co-authors of Mingbo Su

This figure shows the co-authorship network connecting the top 25 collaborators of Mingbo Su. A scholar is included among the top collaborators of Mingbo Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingbo Su. Mingbo Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Bo, Yao Zhao, Yi Zang, et al.. (2024). De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes. Structure. 32(9). 1327–1334.e3. 2 indexed citations

Li, Linjie, Mingbo Su, Weiwei Lu, et al.. (2022). Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins. ACS Medicinal Chemistry Letters. 13(10). 1574–1581. 31 indexed citations

Wang, Shuni, Hong Yang, Mingbo Su, et al.. (2021). 5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma. European Journal of Medicinal Chemistry. 222. 113592–113592. 15 indexed citations

Zhou, Yubo, Yangming Zhang, Honghui Huang, et al.. (2021). Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma. Acta Pharmacologica Sinica. 43(4). 1091–1099. 9 indexed citations

Li, Tengteng, Cheng Peng, Jiqiu Wang, et al.. (2021). Distal mutation V486M disrupts the catalytic activity of DPP4 by affecting the flap of the propeller domain. Acta Pharmacologica Sinica. 43(8). 2147–2155. 5 indexed citations

Li, Shiliang, Shichao Cui, Jiawei Wang, et al.. (2019). Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 62(5). 2348–2361. 24 indexed citations

Su, Mingbo, You Li, Tongchao Liu, et al.. (2019). Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(6). 844–847. 11 indexed citations

Zhao, Dandan, Shaoqian Zhao, Xiao Wang, et al.. (2018). Clinical and Physiological Characterization of Elevated Plasma Glucagon-Like Peptide-1 Levels (Hyperglipemia) in a Dipeptidyl Peptidase IV Mutation Carrier. Frontiers in Endocrinology. 9. 62–62. 1 indexed citations

Wang, Jiang, Mingbo Su, Tingting Li, et al.. (2017). Design, synthesis and biological evaluation of thienopyrimidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors. European Journal of Medicinal Chemistry. 128. 293–299. 21 indexed citations

10.

Zhang, Xuan, Jie Zhang, Mingbo Su, et al.. (2015). Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors. European Journal of Medicinal Chemistry. 95. 127–135. 70 indexed citations

11.

Wang, Sinan, Mingbo Su, Jiang Wang, et al.. (2014). (R)-3-Amino-1-((3aS,7aS)-octahydro-1H-indol-1-yl)-4-(2,4,5-trifluorophenyl)butan-1-one derivatives as potent inhibitors of dipeptidyl peptidase-4: Design, synthesis, biological evaluation, and molecular modeling. Bioorganic & Medicinal Chemistry. 22(23). 6684–6693. 12 indexed citations

12.

Ji, Xun, Chunmei Xia, Jiang Wang, et al.. (2014). Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. European Journal of Medicinal Chemistry. 86. 242–256. 24 indexed citations

13.

Ji, Xun, Mingbo Su, Jiang Wang, et al.. (2014). Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors. European Journal of Medicinal Chemistry. 75. 111–122. 37 indexed citations

14.

Zhou, Yubo, Anhui Gao, Jiayi Cao, et al.. (2014). Curcusone D, a novel ubiquitin–proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(6). 2004–2013. 26 indexed citations

15.

Qiu, Ling, Mingbo Su, Xin Wang, et al.. (2013). Design and Synthesis of 4‐(2,4,5‐Trifluorophenyl)butane‐1,3‐diamines as Dipeptidyl Peptidase IV Inhibitors. ChemMedChem. 8(7). 1104–1116. 13 indexed citations

16.

Zhang, Xuan, Jie Zhang, Linjiang Tong, et al.. (2013). The discovery of colchicine-SAHA hybrids as a new class of antitumor agents. Bioorganic & Medicinal Chemistry. 21(11). 3240–3244. 62 indexed citations

17.

Zhang, Xiaodong, Jiang Wang, Mingbo Su, et al.. (2012). Discovering Novel α‐aminoacyl‐Containing Proline Derivatives with Potent and Selective Inhibitory Activity Against Dipeptidyl Peptidase IV: Design, Synthesis, Biological Evaluation, and Molecular Modeling. Chemical Biology & Drug Design. 80(6). 843–852. 6 indexed citations

18.

Zhang, Lei, Mingbo Su, Jingya Li, et al.. (2012). Design, Synthesis, Structure–Activity Relationships, and Docking Studies of 1‐(γ‐1,2,3‐Triazol Substituted Prolyl)‐(S)‐3,3‐Difluoropyrrolidines as a Novel Series of Potent and Selective Dipeptidyl Peptidase‐4 Inhibitors. Chemical Biology & Drug Design. 81(2). 198–207. 10 indexed citations

19.

Luo, Yu, Haomin Liu, Mingbo Su, et al.. (2011). Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(16). 4844–4846. 9 indexed citations

20.

Spannhoff, Astrid, Yong Kee Kim, Noël J.‐M. Raynal, et al.. (2011). Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees. EMBO Reports. 12(3). 238–243. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact